Electronic ISSN 2287-0237



  1. Lin MF, Lan CY. Antimicrobial resistance in Acinetobacterbaumannii: From bench to bedside. World J Clin Cases2014;2:787-814.
  2. Result of antimicrobial resistantce surveillance [Internet].National Antimicrobial Resistance Surveillance Center,National Institute of Health, Department of Medical Sciences,Ministry of Public Health, Thailand. 2018 (Accessed December1, 2018, at http://narst.dmsc.moph.go.th/).
  3. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrugresistant,extensively drug-resistant and pandrug-resistantbacteria: an international expert proposal for interim standarddefinitions for acquired resistance. Clin Microbiol Infect2012;18:268-81.
  4. Bedenic B, Beader N, Godic-Torkar K, et al. Postantibioticeffect of colistin alone and combined with vancomycin ormeropenem against Acinetobacter spp. with well definedresistance mechanisms. J Chemother 2015;28:375-82.
  5. Zasowski EJ, Rybak JM, Rybak MJ. The beta-Lactams StrikeBack: Ceftazidime-Avibactam. Pharmacotherapy 2015;35:755-70.
  6. Santimaleeworagun W, Wongpoowarak P, Chayakul P, et al.In vitro activity of colistin or sulbactam in combination withfosfomycin or imipenem against clinical isolates of carbapenemresistantAcinetobacter baumannii producing OXA-23carbapenemases. Southeast Asian J Trop Med Public Health2011;42:890-900.
  7. Thapa B, Tribuddharat C, Srifuengfung S, et al. Highprevalence of bla(OXA)-23 in oligoclonal carbapenem-resistantAcinetobacter baumannii from Siriraj Hospital, MahidolUniversity, Bangkok, Thailand. Southeast Asian J Trop MedPublic Health 2010;41:625-35.
  8. Santimaleeworagun W, Thathong A, Samret W, et al.Identification and characterization of carbapenemase genesin clinical isolates of carbapenem-resistant Acinetobacterbaumannii from general hospital in Thailand. Southeast AsianJ Trop Med Public Health 2014;45:874-80.
  9. Boonkerd N, Pibalpakdi P, Tiloklurs M, et al. Class 1 integroncontaining metallo beta-lactamase gene blaIMP-1 in carbapenemresistantPseudomonas aeruginosa in Thailand. J InfectChemother 2009;15:257-61.
  10. Clinical and Laboratory Standards Institute. Performancestandards for antimicrobial susceptibility testing : twenty-fifthinformational supplement. CLSI document M100S; Wayne:PA; 2015.
  11. Poirel L, Walsh TR, Cuvillier V, et al. Multiplex PCR fordetection of acquired carbapenemase genes. Diagn MicrobiolInfect Dis 2011;70:119-23.
  12. Bou G, Cervero G, Dominguez MA, et al. PCR-based DNAfingerprinting (REP-PCR, AP-PCR) and pulsed-field gelelectrophoresis characterization of a nosocomial outbreakcaused by imipenem- and meropenem-resistant Acinetobacterbaumannii. Clin Microbiol Infect 2000;6:635-43.
  13. Yamamoto N, Hamaguchi S, Akeda Y, et al. ClinicalSpecimen-Direct LAMP: A Useful Tool for the Surveillanceof blaOXA-23-Positive Carbapenem-Resistant Acinetobacterbaumannii. PLoS One 2015;10:e0133204.
  14. Teo J, Lim TP, Hsu LY, et al. Extensively drug-resistantAcinetobacter baumannii in a Thai hospital: a molecularepidemiologic analysis and identification of bactericidalPolymyxin B-based combinations. Antimicrob Resist InfectControl 2015;4:2 doi: 10.1186/s13756-015-0043-x.
  15. Provasi Cardoso J, Cayo R, Girardello R, et al. Diversity ofmechanisms conferring resistance to beta-lactams amongOXA-23-producing Acinetobacter baumannii clones. DiagnMicrobiol Infect Dis 2016;85:90-7.
  16. Qian Y, Dong X, Wang Z, et al. Distributions and Types ofMultidrug-Resistant Acinetobacter baumannii in DifferentDepartments of a General Hospital. Jundishapur J Microbiol2015;8:e22935.
  17. Nordmann P. Carbapenemase-producing Enterobacteriaceae:overview of a major public health challenge. Med Mal Infect2014;44:51-6.
  18. Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistenceof blaOXA-23 with blaNDM-1 and armA in clinical isolatesof Acinetobacter baumannii from India. J AntimicrobChemother 2010;65:2253-4.
  19. Santimaleeworagun W, Preechachuawong P, Kerdsin A, et al.Emergence of co-carbapenemase genes, blaOXA23, blaVIM,and blaNDM in carbapenem resistant Acinetobacterbaumannii clinical isolates. Southeast Asian J Trop MedPublic Health 2016;47:1001-7.
  20. Wright H, Bonomo RA, Paterson DL. New agents for thetreatment of infections with Gram-negative bacteria: restoringthe miracle or false dawn? Clin Microbiol Infect 2017;23:704-12.
  21. Moultrie D, Hawker J, Cole S. Factors associated withmultidrug-resistant Acinetobacter transmission: an integrativereview of the literature. AORN J 2011;94:27-36.
  22. Choi WS, Kim SH, Jeon EG, et al. Nosocomial outbreak ofcarbapenem-resistant Acinetobacter baumannii in intensivecare units and successful outbreak control program. J KoreanMed Sci 2010;25:999-1004.